AXQ Capital’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
Other funds holding SANA
AXQ Capital's SANA Position: Q3 2026 in Review
AXQ Capital increased its Sana Biotechnology (SANA) stake by 26% in Q3 2026, buying an estimated $34.3K and bringing the position to 47,625 shares worth $139K. The position accounts for 0.02% of the portfolio, ranked #825.
AXQ Capital first reported a position in SANA in Q2 2025 and has held it in 6 quarters since. The position peaked at $225K in Q4 2025. 200 funds tracked by Wall St. Rank hold SANA as of Q3 2026.
- AXQ Capital held 47,625 shares of Sana Biotechnology worth $139K as of Q3 2026.
- AXQ Capital bought 9,854 Sana Biotechnology shares in Q3 2026, an estimated $34.3K.
- Sana Biotechnology made up 0.02% of AXQ Capital's portfolio in Q3 2026, its #825 holding.
- AXQ Capital first reported a position in Sana Biotechnology in Q2 2025 and has held it in 6 quarters since.
- AXQ Capital's Sana Biotechnology position peaked at $225K in Q4 2025.
- 200 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2026.
Based on AXQ Capital's 13F filing for Q3 2026, filed 12 Nov 2026.